Bernhard Mlecnik

Molecular Biology · 2005–2018

A researcher in the Science corpus: 11 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Bernhard Mlecnik trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jérôme Galon
  2. Michael R. Kosorok
  3. Franck Pagès
  4. Ana Kozomara

Who trusts Bernhard Mlecnik overall

  1. Jérôme Galon
  2. Daniela Bruni
  3. Franck Pagès
  4. Shane Crotty
  5. Joel H. Saltz
  6. Yan Zhang
  7. F. Greten

Papers from Bernhard Mlecnik's perspective

Ordered by how strongly the researchers Bernhard Mlecnik trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
  2. Hallmarks of cancer: the next generation. (Cell)
  3. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. (Journal of Clinical Oncology)
  4. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
  5. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (Journal of Clinical Oncology)
  6. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. (New England Journal of Medicine)
  7. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions (Nature Medicine)
  8. A colorectal cancer classification system that associates cellular phenotype and responses to therapy (Nature Medicine)
  9. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. (Gastroenterology)
  10. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer (Gut)

Their papers